ATE52140T1 - Bestimmungsmethode unter einbeziehung einer phasentrennung und testsatz hierfuer. - Google Patents

Bestimmungsmethode unter einbeziehung einer phasentrennung und testsatz hierfuer.

Info

Publication number
ATE52140T1
ATE52140T1 AT85306916T AT85306916T ATE52140T1 AT E52140 T1 ATE52140 T1 AT E52140T1 AT 85306916 T AT85306916 T AT 85306916T AT 85306916 T AT85306916 T AT 85306916T AT E52140 T1 ATE52140 T1 AT E52140T1
Authority
AT
Austria
Prior art keywords
phase
substances
determining
formation
distinct
Prior art date
Application number
AT85306916T
Other languages
English (en)
Inventor
Larry Edward Morrison
Garfield Paul Royer
Michael James Heller
Original Assignee
Amoco Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amoco Corp filed Critical Amoco Corp
Application granted granted Critical
Publication of ATE52140T1 publication Critical patent/ATE52140T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/805—Optical property

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Networks Using Active Elements (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT85306916T 1984-09-27 1985-09-27 Bestimmungsmethode unter einbeziehung einer phasentrennung und testsatz hierfuer. ATE52140T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/656,011 US4804625A (en) 1984-09-27 1984-09-27 Assay procedures
EP85306916A EP0180327B1 (de) 1984-09-27 1985-09-27 Bestimmungsmethode unter Einbeziehung einer Phasentrennung und Testsatz hierfür

Publications (1)

Publication Number Publication Date
ATE52140T1 true ATE52140T1 (de) 1990-05-15

Family

ID=24631279

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85306916T ATE52140T1 (de) 1984-09-27 1985-09-27 Bestimmungsmethode unter einbeziehung einer phasentrennung und testsatz hierfuer.

Country Status (5)

Country Link
US (1) US4804625A (de)
EP (1) EP0180327B1 (de)
JP (1) JPS61107158A (de)
AT (1) ATE52140T1 (de)
DE (1) DE3577230D1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI853523A0 (fi) * 1985-09-13 1985-09-13 Labsystems Oy Foerfarande foer utfoering av immunobestaemningar med hjaelp av enzymstaempel.
DE3640318A1 (de) * 1986-11-26 1988-06-09 Boehringer Mannheim Gmbh Verfahren und testtraeger zur bestimmung eines analyten
GB8724764D0 (en) * 1987-10-22 1987-11-25 Alcan Int Ltd Enzyme assay method
EP0347256A3 (de) * 1988-06-17 1990-07-11 Tosoh Corporation Verfahren zum Nachweis einer Substanz in einer Probe
AU647459B2 (en) * 1990-01-26 1994-03-24 United States of America, as represented by the Secretary, U.S. Department of Commerce, The A method for quantitatively measuring collagenase
DK0487301T3 (da) * 1990-11-20 2000-09-18 Dade Behring Marburg Gmbh Fremgangsmåde til stabilisering af enzymkonjugater
US6652808B1 (en) * 1991-11-07 2003-11-25 Nanotronics, Inc. Methods for the electronic assembly and fabrication of devices
US6569382B1 (en) * 1991-11-07 2003-05-27 Nanogen, Inc. Methods apparatus for the electronic, homogeneous assembly and fabrication of devices
EP0651783B1 (de) * 1992-07-07 2003-05-28 Abbott Laboratories Alkalische phosphatase-enzyme mit verbesserter spezifischer aktivität in der verwendung als indikator-reagenzien
US6331274B1 (en) 1993-11-01 2001-12-18 Nanogen, Inc. Advanced active circuits and devices for molecular biological analysis and diagnostics
US6225059B1 (en) 1993-11-01 2001-05-01 Nanogen, Inc. Advanced active electronic devices including collection electrodes for molecular biological analysis and diagnostics
DE19539008A1 (de) 1995-10-19 1997-04-24 Boehringer Mannheim Gmbh Reagenz zum Nachweis und zur Isolierung von Kohlehydraten oder Glycanrezeptoren
US6706473B1 (en) 1996-12-06 2004-03-16 Nanogen, Inc. Systems and devices for photoelectrophoretic transport and hybridization of oligonucleotides
US6342397B1 (en) * 1998-06-04 2002-01-29 Erkki Soini Homogeneous biospecific assay using a solid phase, two-photon excitation and confocal fluorescence detection
US6368899B1 (en) 2000-03-08 2002-04-09 Maxwell Electronic Components Group, Inc. Electronic device packaging
EP1384075B1 (de) * 2001-03-28 2009-12-16 Heska Corporation Nachweisverfahren für eine frühe nierenkrankheit in tieren
WO2004084841A2 (en) * 2003-03-27 2004-10-07 Heska Corporation Novel anti-feline albumin antibodies and methods of detecting early renal disease
US20050208671A1 (en) * 2003-12-26 2005-09-22 Nof Corporation Method of analyzing the ratio of activation of terminals of polyoxyalkylene derivatives
US7828954B2 (en) * 2004-09-21 2010-11-09 Gamida For Life B.V. Electrode based patterning of thin film self-assembled nanoparticles
US20080166792A1 (en) * 2007-01-05 2008-07-10 Attar Amir J Detection of analytes in materials liquids using capillary colorimetric detection
US20090203149A1 (en) * 2008-02-13 2009-08-13 General Electric Company Enhanced methods for gas and/or vapor phase analysis of biological assays
CN106324251B (zh) * 2016-08-08 2019-03-29 上海睿康生物科技有限公司 小片段BMG抗体的制备方法及β2-微球蛋白检测试剂盒

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4407943A (en) * 1976-12-16 1983-10-04 Millipore Corporation Immobilized antibody or antigen for immunoassay
SE404553B (sv) * 1977-03-04 1978-10-09 Pharmacia Diagnostics Ab Sett vid bestemningsmetoder involverande biospecifika affinitetsreaktioner
US4277560A (en) * 1978-10-24 1981-07-07 Technicon Instruments Corporation Enzyme immunoassays using immobilized reagents in a flowing stream
SE7812237L (sv) * 1978-11-28 1980-05-29 Pharmacia Diagnostics Ab Koncentrationsbestemning av substanser med formaga att biospecifikt binda molekyler med biologiskt ursprung
US4576912A (en) * 1978-11-30 1986-03-18 Technicon Instruments Corporation Fluoroimmunoassaying
US4268663A (en) * 1979-04-10 1981-05-19 Syva Company Macromolecular glycosidase substrates
US4299916A (en) * 1979-12-26 1981-11-10 Syva Company Preferential signal production on a surface in immunoassays
US4423143A (en) * 1980-12-30 1983-12-27 Syva Company β-D-Galactosidase conjugate for enzyme immunoassays
ATE17048T1 (de) * 1982-05-26 1986-01-15 Boots Celltech Diagnostics Immunoassay.
US4530900A (en) * 1982-09-13 1985-07-23 Seragen Diagnostics Inc. Soluble insoluble polymers in enzymeimmunoassay
US4629689A (en) * 1984-08-29 1986-12-16 Allied Corporation Binding assay with amplified read-out and gas-phase detection

Also Published As

Publication number Publication date
DE3577230D1 (de) 1990-05-23
JPS61107158A (ja) 1986-05-26
EP0180327B1 (de) 1990-04-18
US4804625A (en) 1989-02-14
EP0180327A1 (de) 1986-05-07

Similar Documents

Publication Publication Date Title
ATE52140T1 (de) Bestimmungsmethode unter einbeziehung einer phasentrennung und testsatz hierfuer.
Yulaev et al. Development of a potentiometric immunosensor for herbicide simazine and its application for food testing
ATE311591T1 (de) System zur elektrochemischen quantitativen analyse von analyten in einer festphase
DE3882040D1 (de) Verfahren und vorrichtungen zur durchfuehrung von untersuchungen.
ES549895A0 (es) Procedimiento para detectar y determinar un analito con pro-piedades de fijacion bioafines en una muestra liquida
DE69733560D1 (de) TESTVERFAHREN UND REAGENZIEN ZUR QUANTIFIZIERUNG VON hBNP
EP0384130A3 (de) Herzinfarkt-Immunoassay
CA2081559A1 (en) Determination of analytes in biological fluids in the presence of substances interfering with assays therefor
DE3580640D1 (de) Testverfahren.
Lloyd et al. Salivary creatinine assays as a potential screen for renal disease
LV10538A (lv) Imunologiski saistamas vielas noteiksanas panemiens biologiska skidruma un diagnostikas lidzeklis
EP1234053A4 (de) Vorrichtung und verfahren zum bestimmen der koagulation in flüssigproben
EP0232816A3 (en) Heterogeneous specific binding assay employing an aggregatable binding reagent
US3912805A (en) Reagent and assay for human fibrinogen degradation products
ATE101722T1 (de) Qualitativer enzymtest zur visuellen auswertung.
DK314987A (da) Fremgangsmaade til specifik bestemmelse af serumfructosaminindhold samt hertil egnet reagensblanding
ATE210825T1 (de) Küvette für eine analysevorrichtung, verfahren und diagnostischer testsatz zur feststellung von analyten in vollblutproben
CA2283154A1 (en) Method and apparatus for measurement of blood substitutes
JPS57132060A (en) Peculiarly bonding protein and method of measuring one component in reaction of material able to be bonded thereto
Ali et al. Immunochemical LD1 assay for myocardial infarction
Van den Besselaar et al. The use of evacuated tubes for blood collection in oral anticoagulant control
DE69026497D1 (de) Verfahren zur prüfung von d-vanillylmandelsäure und reagenz und satz dafür
DE3781841D1 (de) Diagnostisches immuntest-verfahren mittels festphasenabscheidung.
RU2041462C1 (ru) Система для разделения фракций при определении содержания вещества в пробе
RU2148U1 (ru) Индикаторная полоска для анализа состава биологических жидкостей

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties